Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis-Reference-Cited by-同舟云学术

Optimized Antifungal Therapy for Chronic Pulmonary Aspergillosis

Published:2024-07-31 Issue:3 Volume:65 Page:59-65
ISSN:2185-6486
Container-title:Medical Mycology Journal
language:en
Short-container-title:Medical Mycology Journal

Author:

Yagi Yusuke¹²,Yamagishi Yuka²³,Hamada Yukihiro¹

Affiliation:

1. Department of Pharmacy, Kochi Medical School Hospital

2. Department of Infection Prevention and Control, Kochi Medical School Hospital

3. Department of Clinical Infectious Diseases, Kochi Medical School, Kochi University

Publisher

The Japanese Society for Medical Mycology

Link

https://www.jstage.jst.go.jp/article/mmj/65/3/65_59/_pdf

Reference46 articles.

1. 1) Committee for the development of guidelines for deep mycosis: Guidelines for diagnosis and treatment of deep mycosis 2014. Kyowa Kikaku, Tokyo, 2014; p.215–61. (in Japanese)

2. 2) Committee for the Preparation of Guidelines for the Diagnosis and Treatment of Aspergillosis, The Japanese Society for Medical Mycology: Guidelines for the Diagnosis and Treatment of Aspergillosis 2015. p.127, The Japanese Society for Medical Mycology, Tokyo, 2015. (in Japanese)

3. 3) Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al: Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63: e1–60, 2016.

4. 4) Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al: Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 47: 45–68, 2016.

5. 5) Koyama K, Ohshima N, Suzuki J, Kawashima M, Takeda K, Ando T, et al: Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance treatment by antifungal triazoles. J Infect Chemother 20: 375–9, 2014.